As we age, our cellular powerhouses—the mitochondria—gradually lose their structural integrity and efficiency. While researchers have long understood that genetic defects can cause mitochondria to fail, the “natural” trigger for their decline in healthy individuals has remained elusive. A new study published in Nature Communications suggests the culprit may be a progressive shortage of phosphatidylcholine (PC), a vital lipid required to maintain the fluidity and shape of mitochondrial membranes.
Using a longitudinal multi-omics approach in Caenorhabditis elegans , researchers identified that metabolic decline is a distinct “late-stage” event in the aging process. While early aging is dominated by failures in mRNA splicing and protein stability, the final transition to old age is marked by a massive downregulation of the enzymes SAMS-1, PMT-1, and PMT-2. These proteins are responsible for synthesizing S-adenosylmethionine (SAM) and using it to create PC via the methylation-dependent pathway.
When this pathway falters, PC levels drop, causing the normally tubular mitochondrial network to fragment into inefficient dots. This structural collapse leads to a significant drop in oxygen consumption and a loss of “metabolic plasticity”—the ability of an organism to adapt its metabolism to stressors. Strikingly, long-lived mitochondrial mutants were found to naturally maintain higher levels of SAMS-1, effectively bypassing this age-related metabolic cliff.
The researchers demonstrated that this decline is not inevitable. By supplementing the diet with either PC or its precursor, choline, they were able to restore mitochondrial integrity and respiration in aged nematodes. Further analysis of human data from the GTEx and UK Biobank cohorts suggests this mechanism is conserved across species. In humans, PC levels decline with age, particularly in post-menopausal women, and low PC levels correlate strongly with clinical markers of poor aging, such as slower walking speed, reduced memory strength, and elevated systemic lactate. This identifies PC synthesis as a malleable, high-leverage target for interventions designed to extend healthy human lifespan.
Actionable Insights
The study provides a clear rationale for prioritizing choline and phosphatidylcholine (PC) intake, particularly in middle and late life, to preserve mitochondrial function.
-
Choline as a Practical Precursor: Choline supplementation (30 mM in worms) successfully bypassed the age-related block in the methylation-dependent PC synthesis pathway by utilizing the CDP-choline (Kennedy) pathway. Choline is water-soluble, stable, and more bioavailable than SAM or raw PC.
-
Phosphatidylcholine Repletion: Direct PC supplementation (100 mg/L) restored mitochondrial morphology and improved oxygen consumption rates (OCR).
-
Targeting Metabolic Plasticity: PC repletion is especially protective during mitochondrial stress (e.g., metformin exposure), suggesting it may be a necessary co-intervention for individuals using metabolic modulators in old age.
-
Diagnostic Markers: Clinicians and biohackers should monitor the PC/TFA ratio and systemic lactate. High lactate and low PC/TFA are indicative of mitochondrial uncoupling and metabolic impairment.
-
Menopause Sensitivity: Post-menopausal women showed the steepest decline in relative PC levels, suggesting this demographic may derive the highest benefit from targeted PC or choline repletion.
Source:
- Open Access Paper: Aging-associated decline of phosphatidylcholine synthesis is a malleable trigger of natural mitochondrial aging
- Institutions: Leibniz Institute on Aging - Fritz Lipmann Institute (FLI); Shenzhen University Medical School; University of Graz.
- Country: Germany, China, Austria.
- Journal: Nature Communications, Published: 18 April 2026
- Impact Evaluation: The impact score of this journal is approximately 14.7, evaluated against a typical high-end range of 0–60+ for top general science, therefore this is an Elite impact journal.